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Abstract
Short interspersed repetitive elements (SINEs) are highly repeated sequences that account for a significant proportion of
many eukaryotic genomes and are usually considered ‘‘junk DNA’’. However, we previously discovered that many AmnSINE1
loci are evolutionarily conserved across mammalian genomes, suggesting that they may have acquired significant functions
involved in controlling mammalian-specific traits. Notably, we identified the AS021 SINE locus, located 390 kbp upstream of
Satb2. Using transgenic mice, we showed that this SINE displays specific enhancer activity in the developing cerebral cortex.
The transcription factor Satb2 is expressed by cortical neurons extending axons through the corpus callosum and is a
determinant of callosal versus subcortical projection. Mouse mutants reveal a crucial function for Sabt2 in corpus callosum
formation. In this study, we compared the enhancer activity of the AS021 locus with Satb2 expression during telencephalic
development in the mouse. First, we showed that the AS021 enhancer is specifically activated in early-born Satb2
+ neurons.
Second, we demonstrated that the activity of the AS021 enhancer recapitulates the expression of Satb2 at later embryonic
and postnatal stages in deep-layer but not superficial-layer neurons, suggesting the possibility that the expression of Satb2
in these two subpopulations of cortical neurons is under genetically distinct transcriptional control. Third, we showed that
the AS021 enhancer is activated in neurons projecting through the corpus callosum, as described for Satb2
+ neurons.
Notably, AS021 drives specific expression in axons crossing through the ventral (TAG1
2/NPY
+) portion of the corpus
callosum, confirming that it is active in a subpopulation of callosal neurons. These data suggest that exaptation of the
AS021 SINE locus might be involved in enhancement of Satb2 expression, leading to the establishment of interhemispheric
communication via the corpus callosum, a eutherian-specific brain structure.
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Introduction
Retroposons are highly repeated sequences that are dispersed
throughout eukaryotic genomes, in which they copy themselves to
RNA and integrate back into the genome at a new site by a ‘‘copy-
and-paste’’ mechanism [1–5]. SINEs (short interspersed repetitive
elements) and LINEs (long interspersed repetitive elements) are
two major classes of retroposons. Remarkably, the human genome
project revealed that ,42% of the human genome is made up of
retroposons [6]. Most transposable elements are non-functional
and are commonly regarded at ‘‘junk DNA’’. At present, however,
there are many examples in which retroposons - including SINEs -
have acquired function during evolution, a process called
exaptation. Exaptation is a kind of adaptation and was originally
proposed by Gould and Vrba for cases in which original
morphological functions could be altered during evolution to
obtain new functions [7]. One such example is feathers, which
were originally utilized for insulation but later used for flight.
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originally non-functional but later acquired function during
evolution [8]. The functions acquired by retroposons are quite
diverse. Retroposons are sometimes used as promoters for
transcription [9], poly(A) signals, enhancers [10], and silencers
[11,12]. Some retroposons that contain a sequence for a splice
donor or acceptor site have been ‘‘exonized’’ to encode amino
acids that are part of a protein [13,14]. One SINE is involved in
chromatin modification [15]. In each of these cases, exaptation
occurred relatively recently in terms of an evolutionary time scale,
and there are very few examples of retroposons that were involved
in macroevolutionary processes such as the acquisition of
mammalian-specific phenotypes.
In recent years, alignment of many genome sequences has
revealed that ,5% of the human genome is conserved among
vertebrates and is subject to purifying selection, and that protein-
coding regions comprise only ,1.5% of the genome [16].
Accordingly, the remaining 3.5% of the human genome
corresponds to conserved non-coding elements (CNEs) [17].
CNEs are clade-specific, that is, some are conserved among
primates [18] or mammals [19–22], others are conserved among
amniotes, and others are conserved among all vertebrates [17,23–
25]. It should be noted that the number of protein-coding genes is
almost the same among all vertebrates (20,000–30,000) and the
evolution of such genes is highly conservative, making it difficult to
explain morphological macroevolution by changes in protein
sequences alone. CNEs are now considered to be a key element
responsible for macroevolution or clade-specific phenotypes. In
particular, it is presumed that CNEs conserved among mammals
are responsible for contributing to mammalian-specific phenotypes
such as the placenta, diaphragm, mammary gland, secondary
palate, and neocortex [26].
To elucidate the biological significance of CNEs, enhancer
analyses based on transgenic assay systems in the mouse have been
applied [27–29]. Interestingly, these studies have pointed to a
strong bias in the activity of CNEs as enhancers in the developing
nervous system [27,28,30]. In most cases, however, detailed
biological and developmental analyses, such as the identification of
genes regulated by the enhancer and/or the demonstration of the
enhancer’s role in developmental processes at the cellular level, are
still lacking. Therefore, to fully understand the association between
the gain or alteration of transcriptional regulation systems
involving CNE enhancer function and its impact on morpholog-
ical and developmental evolution, it is necessary to combine multi-
disciplinary approaches including bioinformatics, extensive profil-
ing of the enhancer function using transgenic mice, and
developmental and neurobiological studies.
One of the most interesting discoveries in transposon biology is
that some CNEs were derived from ancient transposed elements
[31–36], indicating that exaptation was also common in the distant
past, as first exemplified by amniote-specific SINE1s (AmnSINE1s)
[26,30,33], living fossil SINEs (LF-SINEs) [31], and mammalian
interspersed repeat SINEs (MIR-SINEs) [37]. Surprisingly, it was
later shown that at least 16% of eutherian-specific CNEs were
derived from transposons [35]. Furthermore, some CNEs derived
from SINEs were characterized as cis-regulatory elements using
mouse transgenic enhancer assays [30,31,37]. These findings
provide new insights into the contribution of transposable elements
to the evolution of various organisms [38] and possible regulatory
networks [39], because SINEs are repetitive sequences and can
share the same binding sites for potential trans-acting factors in
different loci of the genome.
Copies of AmnSINE1 are distributed in human, mouse,
opossum, and many other mammalian genomes as well as the
chicken genome [33]. Remarkably, ,14% of the AmnSINE1 loci
found in the human genome are highly conserved in evolutionarily
distant species, most of which are found specifically in mammals as
CNEs [33,40]. This suggests that, after they originated in a
common ancestor of amniotes (mammals, birds, and reptiles),
more than 100 AmnSINE1 loci were exapted in a common
ancestor of mammals (a mammalian-specific exaptation burst) and
are now under purifying selection in mammals [26,30,33].
Namely, some of these AmnSINE1s obtained functions in the
mammalian lineage and have survived for ,300 million years.
Moreover, this mammalian-specific exaptation burst appears to
have allowed adaptation to the severe conditions (e.g., super-
anoxia) that resulted from geological events during the Permian-
Triassic mass extinction 250 million years ago [26].
Previously, lacZ transgenic mouse systems were used in
enhancer assays to test the activities of AmnSINE1 loci [30].
Two of the AmnSINE1 loci, AS071 and AS021, were shown to
have enhancer activity consistent with the expression pattern of
neighboring genes involved in brain formation [30]. These
analyses also showed that the AS021 locus functions as a specific
enhancer in the developing cerebral cortex, and its candidate
target gene was suggested to be Satb2. Satb2 is a transcription
factor that binds to the matrix attachment DNA regions [41,42].
Satb2 is expressed in the developing neocortex, maxilla, mandible,
and skeleton [41,43,44] and contributes to the formation of
mammalian-specific brain structures such as the corpus callosum
and neocortex [42,45]. Whether the AS021 SINE locus is involved
in the regulation of Satb2 expression during cortical development
and in the evolution of mammalian-specific brain structures
remains unsolved.
One of the main evolutionary acquisitions of mammals is the
six-layered neocortex, which develops from the dorsal telenceph-
alon (pallium), the most anterior part of the brain [46]. In the
neocortex, neurons within each layer are generated at similar
times and share similar morphology and patterns of connectivity
[47]. They can also be subdivided into two major groups: deep-
layer and superficial-layer neurons. Superficial-layer neurons are
located in layers 2 to 4; those in layer 2 and 3 interconnect
different cortical areas by projecting ipsilaterally or contralaterally,
whereas those in layer 4 receive the major input connections.
Deep-layer neurons are positioned in layers 5 and 6, and the
majority sends axons to subcortical targets in the spinal cord, pons,
tectum, and thalamus. During neurogenesis, deep-layer neurons
(layers 6 and then 5) are generated first (E11.5 to E14.5 in mice),
followed by layers 4, 3 and 2 (E14.5 to E17.5). Other vertebrates
do not display similar numbers of neurons or layers or this inside-
out sequence of positioning [48].
The corpus callosum, a commissural fiber tract, is a structure
that is specific to the brain of placental mammals [49]. The corpus
callosum and the placenta are probably the most recent
acquisitions in mammalian evolution. The vast majority of
Satb2-expressing neurons in both superficial and deep layers of
the neocortex contribute to the formation of the corpus callosum.
Some Satb2-expressing neurons in the deep layers may project
axons into other axonal tracts [42]. In addition, Satb2 directly
specifies a callosal neuronal phenotype by suppressing subcortical
projection fate through direct repression of Ctip2 transcription
[42,45].
To characterize the genetic function of the AS021 enhancer, we
performed a detailed analysis of the enhancer activity of the
AS021 locus in vivo and compared it to Satb2 expression in the
developing cerebral cortex. We show that AS021 enhances
expression in a specific population of Sabt2-expressing neurons
located predominantly in deep layers, paralleling the kinetics of
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role of AS021 in the specific enhancement of Satb2 expression in
deep-layer cortical neurons. This is the first report in which the
precise function of a mammalian-specific enhancer derived from a
SINE has been analyzed in detail at the cellular level during mouse
cortical development.
Results
Characterization of the AS021 locus
The AS021 locus is a CNE that is conserved among all mammals
except monotremes. AS021 locus is not found in the platypus
genome, suggesting exaptation of this SINE locus in a common
ancestor of Theria (Figure 1). Previously we showed that
approximately half of this locus can be aligned with the 39 half of
the AmnSINE1 consensus sequence, the total length of which is 570
base pairs (bp) (Figure 1A, Figure S1). A Maximum-Parsimony tree
of the locus shows extremely short internal branches, suggesting a
small number of nucleotide differences among species and that the
sequence might be under purifying selection during evolution
(Figure 1B). Notably, a synteny of genes surrounding the AS021
locus, including Satb2, C2orf69, C2orf60, C2orf47, Spats2l, Kctd18,
Sgol2,a n dAox1, is highly conserved among mammals (e.g., human,
mouse, dog, and opossum; Figure 1C). To test whether the AS021
locus displays enhancer activity, we previously produced an AS021-
HSF51 construct consisting of an 800-bp region containing the
mouse AS021 locus, the mouse hsp68 promoter, and the bacterial
lacZ reporter gene, and we used the construct in transient enhancer
assayswith transgenicmice [30] (Figure S2).WeshowedthatAS021
drives specific expression of the lacZ gene in the dorsal
telencephalon starting at E11.5 and progressively expanding to
the entire pallium at E13.5 [30]; however, detailed spatiotemporal
activity of the enhancer was still unknown.
Here, to further analyze the enhancer activity of the AS021
locus during brain development, we generated stable transgenic
mouse lines using the AS021-HSF51 construct (Figure S2). Two
lines were established that reproducibly express b-galactosidase
(bgal) in the telencephalon as observed in previous experiments
using transient transgenic mice [30]. This suggests that the AS021
sequence shows a consistent enhancer function regardless of
integration site in transgenic mice. One of these lines was further
analyzed by X-Gal staining to determine the time course of bgal
expression.
The onset of expression in the telencephalon at E11.5 was
observed only in post-mitotic cells in the lateral side of the pallium
at caudal levels (Figure 2A,F,K), corresponding to the prospective
piriform cortex. At E12.5, bgal expression expanded dorsally into
the prospective lateral cortex (Figure 2B,G,L), and by E13.5, it
covered the entire pallium including the prospective neocortex
(Figure 2C,H,M) following the lateral-to-medial gradient of
cortical maturation. Coronal sections at E13.5 revealed expression
in the post-mitotic compartment, including the marginal zone
(MZ) that will become layer 1 in the mature cortex, and the
cortical plate (CP), a densely packed zone of post-mitotic cells [50]
beneath the MZ that will become layers 2–6 [51] (Figure 2H,M).
Moreover, expression appeared to start beneath the CP in the
intermediate zone (IZ) (Figure 2H,M), through which differenti-
ating neurons migrate toward their final location. Similar
expression in the cerebral cortex was still observed at later stages
of embryonic development (E14.5–E16.5) and at postnatal day 0
(P0) (Figure 2D,E,I,J,N–R), but progressively decreased in the
prospective piriform cortex (Figure 2J,O, black arrowhead).
Interestingly, bgal expression was also observed in axonal tracts,
namely the anterior commissure (ACo) and the corpus callosum
(CC), but not in the internal capsule (IC) (Figure 2P–R). No
expression was observed outside the cerebral cortex at either E16.5
or P0, for example in the striatum (Str), thalamus, or olfactory bulb
(Figure 2P–R and data not shown). Taken together, these results
show that AS021 displays specific enhancer activity in the
developing cerebral cortex with a precise onset of appearance
and spatial distribution in differentiating neurons.
Comparative analysis of expression between AS021-lacZ
and adjacent loci
Genomic comparison throughout mammalian species revealed
conservation of a synteny of 13 genes located within 2 Mbp of the
AS021 locus, namely Hsfy2, Satb2, AK006906/C2orf69, 11134B05/
C2orf60, 9430016H08/C2orf47, DNAPTP6/Spats2l, Kctd18, Sgol2,
Aox1, Aox4, Aox3l1, Bzw1, and Clk1 (Figure 1). The developmental
expression of AS021 was strikingly similar to that of one of these
genes, Satb2 [30]. To test whether any of the other genes also have
a similar expression pattern in the developing neocortex, we
examined their expression patterns in the telencephalon of E16.5
and P0 animals using in situ hybridization. Of these 13 genes, only
Bzw1 (Figure S3 and Table S1) and Satb2 (Figure 3 and Table S1)
were expressed in the telencephalon at E16.5 and P0. A low level
of Bzw1 expression was detected in the developing cortex and in
the hippocampus, thalamus, and olfactory bulb (Figure S3 and
data not shown). Because the expression pattern for this gene did
not correlate with that of AS021-lacZ and because its transcription
start site is far (.1 Mbp) from the AS021 locus in the mouse
genome, we did not pursue this gene further. Interestingly, the
transcription start site of Satb2 is located 359 and 392 kbp from the
AS021 locus in the mouse and human genomes, respectively, and
the gene is expressed in the developing cortex with a similar onset
and pattern of expression, starting in the prospective piriform
cortex at E11.5 [41]. We found that Satb2 expression progressed
dorsally into the CP at later stages and was present throughout the
CP during late embryogenesis (Figure 3A,B). Moreover, like
AS021-lacZ (see later section), Satb2 is expressed in neurons
projecting through the CC [42,45].
We conclude that the AS021 enhancer activity correlates both
spatially and temporally with the expression of Satb2 in the
developing cerebral cortex, suggesting strongly that the AS021
locus may serve as a cerebral cortex–specific enhancer of Satb2.
Specific expression of AS021-lacZ in a subpopulation of
deep-layer Satb2
+ commissural neurons
To further analyze the relationship between AS021 enhancer
function and Satb2 expression, we performed co-immunostaining
for bgal and Satb2. As shown in Figure 4A–A20, bgal and Satb2
were co-expressed in the prospective piriform and lateral cortices
at E12.5, consistent with the onset of Satb2 protein expression
[41]. At E12.5, the vast majority (,90–97%) of bgal
+ cells in the
CP expressed Satb2 (Figure 4A–A20,E,G), and most Satb2
+ cells
(,87–96%) expressed bgal. bgal expression appears to start in the
IZ, correlating with the onset of Satb2 mRNA expression in the IZ
[41,45]. From E13.5, as neurogenesis proceeds in the piriform
cortex, the proportion of Satb2
+ cells co-expressing bgal
decreased, but the proportion of bgal cells expressing Satb2
stayed constant (Figure 4B,D,E). The identity of bgal
+ cells in the
prospective neocortex was analyzed using an antibody for Tbr1, a
marker of early-born glutamatergic neurons at E13.5. All bgal
+
cells in both the MZ and CP co-expressed Tbr1 (Figure S4),
indicating that they represent early-born glutamatergic cortical
neurons. Interestingly, the number of Satb2
+ neurons not
expressing bgal increased at later stages of neocortical develop-
A Neocortical Satb2 Enhancer Derived from SINE
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layers start to populate the CP (Figure 4F,G). By P0, bgal and
Satb2 co-expression was mostly detected in deep layers 5–6 of the
entire pallium, and to a lesser extent in the more superficial layers
2–4 (Figure 5A–D). Indeed, at this stage, bgal
+ cells represented
81.1563.61% of Satb2
+ neurons in layers 5–6 (bins 1–6 in
Figure 5B–D), but only 15.3064.67% of Satb2
+ neurons in layers
2–4 and the MZ (bins 7–10). These results indicate that bgal
expression driven by the AS021 enhancer correlates with Satb2
expression in early-born but not late-born neocortical neurons.
Figure 1. Conservation of the sequence and surrounding gene synteny of the AS021 locus. (A) The human AS021 locus in the UCSC
Genome Browser (chr2:200,424,671–200,425,272, hg18). The black bar corresponds to the estimated AmnSINE1-derived region, which is almost
identical to the conserved region among mammals. The 39 half of the AS021 conserved region is homologous to the AmnSINE1 consensus sequence
(above, 570 bp), and a sequence alignment of the region is shown in Figure S1. Colors in the AmnSINE1 consensus sequence represent the 5S rRNA–
derived promoter (red), tRNA-derived region (yellow), Deu-domain (green), and 39-tail region (blue). (B) A maximum-parsimony tree using the 39 half
of the AS021 locus from mammals. Note that the internal branch lengths are very short, suggesting the strong selective constraint of the locus. The
AmnSINE1 consensus sequence was used as an outgroup. (C) The conserved gene synteny in the region around the AS021 locus (,1.6 Mb window)
among human, mouse, dog, and opossum.
doi:10.1371/journal.pone.0028497.g001
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between P0 and P2 along with the reduction of AS021-lacZ
activity (Figure 5E–G0 and S5), correlating with the reported
reduction of Satb2 expression at P7 [45]. In contrast, strong
expression of Satb2, but not bgal, was observed in layers 2–3 at
P2. At P21, corresponding to an adult stage, bgal expression was
restricted to cells located in the deepest layers of the cerebral
cortex (Figure S5). Therefore, the AS021 enhancer recapitulated
the expression of Satb2 in deep but not in superficial layers after
birth as well as during embryogenesis (Figure 5E–F0). This also
confirms that the AS021 enhancer activity is not suppressed in
terminally differentiated deep-layer neurons.
Moreover,inthe prospective layers 5–6 at P2, somebgal
+/Satb2
+
neurons also expressed Ctip2, a protein required for formation of
corticospinal connections [42,52] (Figure 5F–G09, white arrow-
heads). It has previously been suggested that Satb2
+/Ctip2
+ neurons
in layer 5 project to either the ACo or cortico-subcortical tracts [42],
whereas Satb2
+/Ctip2
2 neurons (Figure 5F–G09, black arrowheads)
extend commissural axons towardthe CC [42]. Indeed, AS021-lacZ
appeared to label axons in the CC and ACo at P0 and P2
(Figure 5A,E and Figure 6A–C9, white arrowheads). We performed
co-immunostainingforbgalalongwithTAG1andNPY,whichstain
the dorsal and ventral domains of the CC, respectively [53].
Interestingly, we found that bgal expression co-localized with NPY
in the ventral domain of the CC at P0 (Figure 6D-D0), but not with
TAG1 in the dorsal CC (Figure 6B–D09).
Together, these results show that the AS021-lacZ continues to
be co-expressed with Satb2 in neurons located in the deep layers at
postnatal stages. The vast majority of these neurons project their
axons across the ventral CC. All these data support the notion that
AS021 might serve as an enhancer for Satb2 expression in early-
generated callosal neurons.
Discussion
AS021 SINE enhancer activity recapitulates Satb2
expression in early-born but not late-born cortical
neurons
In this study, we have analyzed the enhancer activity of the
AS021 SINE locus in the developing cerebral cortex. We analyzed
the 13 genes found within 2 Mbp, and showed that the pattern of
Figure 2. Expression patterns of AS021-lacZ in the telencephalon of transgenic mice during embryogenesis. A–Q. X-Gal staining for b-
galactosidase activity on AS021-lacZ embryos at E11.5 (A,F,K), E12.5 (B,G,L), E13.5 (C,H,M), E14.5 (D,I,N), E15.5 (E,J,O), E16.5 (P,Q) and P0 (R) shows a
dynamic pattern of expression in the dorsal telencephalon. (A–E) Frontal views of whole-mount stained heads. (F–O) Two coronal sections at rostral
(F–J) and caudal (K–O) levels of the corresponding stages. (P–R) Coronal sections at E16.5 (P,Q) and P0 (R). The enhancer activity of AS021 starts at
E11.5 in the lateral wall of the caudal telencephalon (prospective piriform cortex; black arrowhead in A,F,K) and progressively expands into the entire
pallium between E12.5 and E13.5 (B,C,G,H,L,M). At E15.5–P0, expression is still observed in the entire pallium, within the deeper region of the cortical
plate (D,E,I,J,N–Q). Scale bars: 2 mm (A–E), 0.2 mm (F,K), and 0.5 mm (G–J,L–R).
doi:10.1371/journal.pone.0028497.g002
Figure 3. Satb2 mRNA expression pattern in the developing
cerebral cortex. In situ hybridization for Satb2 mRNA in E16.5 (A) and
P0 (B) wild-type cerebral cortices. Satb2 expression is detected in the
developing cortical plate but not in the hippocampus.
doi:10.1371/journal.pone.0028497.g003
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+ neurons. (A–C) Immunostaining for Satb2 (red) and bgal (green) on coronal
sections of E12.5 (A-A20), E13.5 (B), and E14.5 (C-C20) AS021-lacZ embryos confirms that AS021 drivesbgal expression within Satb2
+ cells from the
earlier stages of Satb2 expression in the developing cerebral cortex. (A1-A10,C1-C10) Enlargement of boxed regions within the prospective piriform
cortex in A and C, respectively, showing that most Satb2
+ neurons also express bgal at E12.5 (white arrowheads) and to a lesser extent at E14.5, as an
increased number of Satb2
+ neurons do not express bgal (black arrowheads). (A2-A20,C2-C20) Enlargement of boxed regions within the prospective
lateral cortex in A and C, respectively. (D) Graph shows the percentage of Satb2
+ neurons that co-express bgal (bgal
+) in the piriform cortex at early
stages of cortical development and reveals a decrease in the number of Satb2
+ neurons that also display AS021 activity during the progression of
corticogenesis (87.5460.65% at E12.5, 74.0360.64% at E13.5, 42.3261.07% at E14.5, and 36.4367.85% at E16.5). (E) Percentage of bgal
+ neurons that
co-express Satb2 in the piriform cortex. The majority of bGal
+ neurons expresses Satb2 confirming that AS021 drives lacZ expression specifically in
Satb2
+ neurons (90.4962.97% at E12.5, 89.6263.96% at E13.5, 92.9663.25% at E14.5 and 90.5363.03% at E16.5). (F) Percentage of Satb2
+ neurons
that co-express bgal (bgal
+) in the prospective lateral cortex. On the contrary to the piriform cortex, the fraction of Satb2
+ neurons also expressing
bGal in the lateral pallium is stable from E12.5 to E14.5 (96.9761.30% at E12.5, 97.3062.19% at E13.5 and 96.1963.08% at E14.5) and start decreasing
at E16.5 (46.5366.77%). (G) Percentage of bgal
+ neurons that co-express Satb2 in the prospective lateral cortex. Similarly to the piriform cortex, AS021
drives specific lacZ expression in Satb2
+ neurons (96.8861.59% at E12.5, 97.2661.47% at E13.5, 92.0960.52% at E14.5 and 91,6363,08% at E16.5).
Graphs show mean 6 SEM. Scale bars: 100 mm.
doi:10.1371/journal.pone.0028497.g004
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exclusively with the expression of the Satb2 transcription factor in
early-born commissural neurons located in deep layers.
In adults, Satb2 is predominantly expressed in superficial layers
of the neocortex, and the vast majority of Satb2
+ cortical neurons
extend axons across the corpus callosum [41,42,45]. However, a
small subset of Satb2
+ neurons (,30%) is also detected in deep
layers, where Satb2 can be co-expressed with Ctip2 [42]. Here,
we demonstrated that the AS021 SINE element drives expression
of the lacZ reporter gene in Satb2
+ neurons in deep layers that
project axons into the corpus callosum, but not in Satb2
+ neurons
located in superficial layers. The corpus callosum is divided
into ventral and dorsal portions that are innervated by axons
from the superficial and deep neocortical layers, respectively
(Figure 6E) [53]. Accordingly, we showed that AS021 activated
gene expression in Satb2
+ deep-layer neurons projecting into
the ventral CC. From a synteny of 13 genes conserved around the
AS021 locus in mammals, none of the other genes were expressed
in the developing cerebral cortex. Together, these results show
that the AS021 SINE enhancer activity precisely recapitulated
Satb2 expression in a subpopulation of deep-layer commissural
neurons. Although these data are still circumstantial evidence,
they support the possibility that AS021 serves as a distal enhancer
involved in transcriptional control of Satb2 in these neurons.
Moreover, our data may also reflect that expression of Satb2 is
under distinct genetic control in deep versus superficial layers.
Possible involvement of the AS021 SINE locus in the
formation of the corpus callosum through the
enhancement of Satb2 expression
The corpus callosum originated in a eutherian ancestor as a
strategy to minimize interhemispheric transmission time for fibers
connecting primary and secondary sensory areas [54]. Accord-
ingly, acquisition of the corpus callosum was an important event
for the evolution of sensory processing in the eutherian brain. Satb2
is a key determinant of callosal neuron identity and is required for
CC formation. We propose that the exaptation of the AS021 SINE
locus might have contributed to the formation of the ventral CC,
possibly by enhancing expression of Satb2 in deep-layer callosal
projection neurons.
It should be noted that the AS021 SINE locus is conserved
among all therians including the opossum (marsupial), and that the
opossum does not have a CC, but instead has interhemispheric
connections via the ACo and the hippocampal commissure
[54,55]. It will be interesting to examine the expression of Satb2
Figure 5. AS021 activity and Satb2 expression decrease within deep layers at postnatal stages. (A–B0) Immunostaining for Satb2 (red)
and bgal (green) in coronal sections of P0 AS021-lacZ brains. The cortical plate was divided into 10 equivalent bins, with bin 1 corresponding to the
deepest layer and bin 10 corresponding to the most superficial layer. (C-C0) High magnification of boxed region in B showing that only a fraction of
Satb2
+ neurons located in bin 6–7 (corresponding to more superficial layers) also express bgal (white arrowheads). Black arrowheads correspond to
Satb2
+ neurons that do not express bgal. (D) Quantification of the percentage of Satb2
+ neurons co-expressing bgal (bgal
+) within the 10 bins. (E–G09)
Immunostaining for Satb2 (red), Ctip2 (blue), and bgal (green) in coronal sections of P2 AS021-lacZ brains reveals a strong decrease of Satb2 staining
specifically in deep layers. A similar decrease is observed for bgal, confirming the specificity of the AS021 activity. At both P0 and P2, AS021 activity
remains specific to Satb2
+ neurons ($90%) in deep layers (D, H). Almost no co-labeling for bgal and Satb2 is observed in bins 8–10, corresponding to
prospective layers 2–3 (superficial layers). A fraction of bgal
+ neurons that expresses Satb2 also express Ctip2 (white arrowheads in G–G09) in layers 5
and 6. Black arrowheads indicate bgal
+ neurons that express Satb2 but not Ctip2 in layer 6. For each bin, 10–200 bgal
+ cells were counted and 200–
500 Satb2
+ cells were counted in at least two animals for each stage. Graphs show mean 6 SEM. Scale bars: 200 mm (A), 100 mm (B).
doi:10.1371/journal.pone.0028497.g005
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AS021 enhancer in the neocortex of these species. Nevertheless,
the formation of complex structures such as the CC requires the
orchestration of multiple cell-autonomous and non-cell-autono-
mous developmental programs in addition to a Satb2-dependent
pathway [53,56,57]. Moreover, agenesis of the CC has been
observed in both mice and humans in mutations other than Satb2
[56–59], strongly suggesting that the enhancement of Satb2
expression by AS021 in neurons projecting in the ventral CC,
even if proven to occur in acallosal marsupials, might not be
sufficient to drive CC formation alone in these species. Therefore,
in spite of a lack of CC in marsupials, it is expected from the
sequence conservation (Fig. S1) that the marsupial AS021 locus
has similar enhancer property.
CNEs involved in gene expression in the developing
cerebral cortex are not necessarily related to viability
To elucidate the functions of CNEs including ultraconserved
elements, enhancer analyses based on a transgenic assay system in
the mouse have been performed in several laboratories [27–29].
Furthermore, several knockout (KO) mice that lack ultraconserved
elements serving enhancer activities are viable and display no
significant abnormalities in macroscopic phenotypes [60]. One
interpretation of these results is that the high level of DNA
sequence conservation of CNEs does not necessarily correlate
directly with biological significance due to the redundancy of such
enhancer elements.
The recent discovery in Drosophila of ‘‘shadow’’ enhancers with
slightly distinct but overlapping activities [61] is interesting from
Figure 6. AS021 drives lacZ expression in neurons projecting through the corpus callosum. (A) X-Gal staining on 35-mm coronal sections
of P0 AS021-lacZ animals shows bgal
+ projections through the corpus callosum (CC), but also in the external capsule (EC), the striatum, and the
anterior commissure (ACo). In addition, projections through the superficial layers can be observed in the parietal (ParCx) and lateral (LCx) cortices but
not in the dorsal (DCx) and medial (MCx) cortices. bgal
+ neurons can be observed in a vast territory of the cortical plate, with the exception of the
superficial layers. bgal
+ cells are also detected in the claustrum (Cl) and in the piriform cortex (PirCx). (B–C9) Immunostaining for Satb2 (red), bgal
(green), and TAG1 (blue). TAG1 labels the upper domain of the CC, and bgal
+ projections are detected within the lower domain of the corpus
callosum (TAG1
2). B and C are single confocal acquisitions from two independent experiments scanned at the approximate levels of the
corresponding boxes indicated in A. C corresponds to the same level as A and B to a more rostral section with respect to A. (D–D09) Immunostaining
for bgal (green), TAG1 (blue), and NPY (red). Co-expression of bgal and NPY, which labels the lower domain of the CC, confirms the spatial restriction
of bgal
+ projections to the ventral domain of the CC. (E) Schematic representation shows the relative contribution of axonal projections from the
medial and parietal cortices into the dorsal and ventral domains of the CC, respectively [53]. Scale bars: 200 mm (A), 100 mm (B,D).
doi:10.1371/journal.pone.0028497.g006
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distant locations contribute to phenotypic robustness in conditions
of environmental and genetic variability [62]. Changes in cis-
acting elements can promote diversity during evolution, but
maintenance of essential genetic activities is also crucial.
Interestingly, a recent study suggested that a possible shadow
(secondary) enhancer of the Atoh7 gene is responsible for retinal
neurogenesis in humans [63]. They proposed that the primary and
shadow enhancers may cooperatively act in the expression of Atoh7
in retinal ganglion cells. Thus, AmnSINEs acting as shadow
enhancers might have the potential to evolve new regulatory
networks possibly by interacting with existing cis-regulatory
elements without altering the essential functions of developmental
genes.
However, another interpretation of the absence of apparent
phenotypic changes in KO mice is possible [60]. Satb2 mutant
mice exhibit small (,15%) reductions in cortical plate thickness at
E18.5 as well as agenesis of the corpus callosum [45]. Superficial
layers have been reported to account for 80% of callosal
projections, whereas layer 5 contributes only 20% of fibers to
the CC [57]. Because the AS021 SINE element is possibly
involved in expression of Satb2 only in deep-layer neurons (,30%
of total Satb2
+ neurons after P2), phenotypic changes of a KO
mouse of this enhancer element are not expected to be detectable
by macroscopic analysis, even if the AS021 enhancer is the only
element that drives the expression of Satb2 in deep layers of the
neocortex. Moreover, such phenotypic changes are not likely to be
related to viability, as even a total lack of the CC in severe
pathological conditions in humans and mice does not cause
mortality [56,57,59]. Our results suggest that therian-specific
CNEs that serve enhancer activity in the developing cortex are not
likely to be involved in vital functions, but perhaps participate in
fine-tuning cortical neuronal subtype identity and connectivity that
contributes to the increased complexity of integrative functions
and high computational skills in the mammalian brain.
The present study provides the first example in which the
enhancer function of a CNE was precisely analyzed from a
neurobiological point of view using multi-disciplinary approaches
including bioinformatics, mouse genetics, and developmental
neurobiology. It might be difficult to evaluate the absence of
apparent phenotypic changes in KO mice lacking ultraconserved
elements [60] without such a detailed study.
A concept of the regulation of gene expression by
repetitive sequences
It has long been believed that the control of gene expression in
vertebrates is of key importance to explaining various biological
mechanisms including cell differentiation and morphological
evolution; however, most such molecular mechanisms and their
evolution remain enigmatic. In 1969, Britten and Davidson
proposed an innovative idea regarding mechanisms regulating
gene expression in vertebrates [64]. Based on the novel
observation that there are a large fraction of repetitive sequences
in the genomes of vertebrates such as mammals, which had just
started to be recognized at that time, they hypothesized that the
generation and propagation of repetitive elements can provide a
source of new regulatory DNA. Because of homology in repetitive
elements, complex hybrids can form between the DNA strands
and/or their transcripts, and these might be involved in higher-
order regulation of gene expression. Although several examples of
exaptation of SINEs and LINEs (e.g., Alu and L1s) have been
reported [65], repetitive sequences such as transposable elements
were generally regarded as genomic parasites until recently.
The discovery of CNEs [17,19,20,23–25,31] changed this
situation dramatically. Functional studies of CNEs have become
an important research direction in comparative genomics,
developmental biology, and evolutionary biology [24,27–29].
Using bioinformatics, Bejerano et al. [66] showed that, among
the hundreds of thousands of CNEs distributed in mammalian
genomes, thousands can be clustered based on sequence similarity.
In addition, a number of CNEs contain significant regulatory
motifs (such as CTCF [CCCTC-binding factor] insulator sites
[67]) and are located close to genes associated with developmental
regulatory functions [24]. This implies that many similar kinds of
regulatory elements may be distributed throughout mammalian
genomes. The origins of such repetitive CNEs might become an
important clue to validate and shape Britten and Davidson’s
model [64], but remained unsolved until recently.
One of the most interesting discoveries in transposon biology is
that some CNEs were derived from ancient retroposons [31,33].
We previously found that AmnSINE1 represents a portion of the
repetitive CNEs, most of which are conserved in mammals [33].
This study, together with a study on LF-SINEs [31], suggests for
the first time that retroposon insertions can be a source of
acquisition of new regulatory networks. A number of mammalian
CNEs are known to be derived from transposable elements
[32,34–36], and several of these function as enhancers [30,31,37].
Thus, a detailed functional analysis of exapted retroposons as
shown in this study is more than a concrete demonstration of
Britten and Davidson’s model. It is also a key milestone toward
understanding how alteration or acquisition of gene regulatory
mechanisms leads to the evolution of clade-specific morphological
traits such as the mammalian neocortex.
Possible gene regulatory networks derived from
AmnSINE1
The AS021 SINE locus is one of 124 AmnSINE1s that were
exapted in a common ancestor of mammals [30]. Because of their
repetitive nature, we attempted to address whether possible gene
regulatory networks derived from AmnSINE1s exist. The
conserved region of the AS021 locus (Figure 7A, gray and black
bar) contains 27 transcription factor binding sites that are
predicted from conservation in human-mouse-rat alignment and
the Transfac matrix database. We focused on the following 15
sites: Pax6, two Oct-1, FoxD3, HLF, POU3F2, E4BP4, FoxJ2,
CREBP1, Brn-2, Cart-1, Nkx6.1, S8, SEF-1, and CDPCR-3
(Figure 7A). Interestingly, our enhancer assay for the AS021
sequence with mutations for all 15 binding sites does not show any
enhancer activity in the telencephalon of E13.5 embryos (Izawa,
Nishihara and Okada, unpublished data) suggesting that at least
one of the 15 trans-acting factors is responsible for the AS021 distal
enhancer activity. This result prompted us to consider the
possibility that multiple AmnSINE1 loci, including the AS021
SINE locus, participate in similar regulatory networks by binding
to the same trans-acting factor(s). To investigate whether other
AmnSINE1s in CNEs, as well as the original (consensus)
AmnSINE1 sequence [33], contain the same binding sites as the
AS021 SINE locus, we focused on the seven binding sites for Oct-
1, Brn-2, Cart-1, Nkx6.1, S8, SEF-1, and CDPCR-3 present in the
39 half of the AS021 SINE locus that has homology with the
AmnSINE1 consensus sequence (Figure 7A, black bar). Interest-
ingly, among the 124 conserved AmnSINE1 sequences collected
by Sasaki et al. [30], multiple AmnSINE1 loci share the binding
sites for Oct-1, Brn-2, Cart-1, Nkx6.1, and S8 in the conserved
sequence (Figure 7B). These data suggest that the original
(consensus) AmnSINE1 sequence might have retained these
binding sites (Figure 7C), having facilitated some of the amplified
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PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e28497Figure 7. Distribution of transcription factor binding sites in AS021 and other AmnSINE1 loci. (A) Transcription factor binding sites in the
conserved region of the AS021 locus. Black and gray bars indicate that the sequence is homologous or not homologous to the AmnSINE1 consensus
sequence, respectively. The white bar represents sequences not derived from the SINE. The seven transcription factors in bold were further analyzed
in (B). (B) Distribution of the transcription factor binding sites in AmnSINE1-derived CNEs. The binding sites of Oct-1, Brn-2, Cart-1, Nkx6.1, S8, SEF-1,
and CDP CR3 were searched in the 124 conserved AmnSINE1 loci collected by Sasaki et al. [30]. Colored bars (Y-axis) represent the number of the
transcription factor binding sites identified from the 124 loci in the forward (above) and reverse (below) strands of the corresponding AmnSINE1
consensus sequence (X-axis). Note that most of the binding sites derived from AmnSINE1 are in the Deu-domain. The binding sites, indicated by
arrows with names of the transcription factors, were aligned as shown in (C). (C) Sequence alignments of the representative binding sites of five
transcription factors (seven OCT-1, four Brn-2, nine Nkx6.1, three Cart-1, and three S8 binding sites), along with the binding motifs obtained from the
Transfac database and the AmnSINE1 consensus sequence. The Transfac ID of each motif is shown in parentheses.
doi:10.1371/journal.pone.0028497.g007
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mammals. These trans-acting factors, which are also expressed in
the developing mammalian brain, may bind to distant AmnSINE1
loci and may be involved in the same regulatory network of gene
expression which was generated at the time of AmnSINE1
exaptation.
Some of the five transcription factors in Figure 7C are
expressed in the mammalian central nervous system (CNS). For
example, Brn-2 (POU3F2 or Oct-7), a POU domain–containing
homeobox transcription factor, has been associated with
mammalian brain development. Brn-2 is specifically expressed
in neocortical layers 2–5 and can function as an activator as well
as a repressor of transcription in different biological systems
[68,69]. Therefore, it is possible that the presence of the Brn-2
binding site in the AS021 locus is involved in the differential
expression of Satb2 between superficial and deep layers of the
neocortex. As shown in Figure 7B, four of the 124 exapted
AmnSINE1 loci, including AS021, share the Brn-2 binding
site. It will be interesting to examine whether these four SINE
loci also function as enhancers for a gene(s) specifically expressed
in deep layers of the neocortex due to the presence of the Brn-2
binding site. In contrast, Oct-1 (POU2F1), another transcription
factor of the POU-homeodomain family, is ubiquitously ex-
pressed in both embryonic and adult mouse tissues [70], but its
function in cortical development has not been analyzed.
Considering that the expression of many developmentally
regulated genes is controlled by POU domain–containing
transcription factors, it is possible that some of the exapted
AmnSINE1 loci are involved in similar regulatory networks
through their common binding sites for these factors. Finally,
because some of the putative transcription factors binding to the
AS021 enhancer are not expressed in the developing cerebral
cortex (e.g., Nkx6.1), it is likely that a combination of
transcription activators and repressors is responsible for the
specific enhancer activity of AS021 in deep-layer Satb2
+ neurons.
Future analysis should elucidate the existence and function of
such complex regulatory systems.
Conclusion
We have shown that the AS021 element may be one of the
enhancers for specific expression in Satb2
+ neurons in the
developing pallium. Interestingly, the enhancer activity of AS021
appeared to be restricted to a subpopulation of early-born Satb2
+
neurons located within deep layers of the cerebral cortex, and was
not observed in superficial layers. In addition, we described
AS021-driven expression within commissural neurons projecting
through the ventral domain of the corpus callosum. These results
suggest that AS021 serves as a distal enhancer for Satb2
transcription in early-born neurons. In that case, we can speculate
that there may be differential regulation of Satb2 expression
between the deep and superficial layers. This is the first study in
which the enhancer function of a CNE was precisely analyzed
from a neurobiological point of view using a multi-disciplinary
approach involving bioinformatics, mouse genetics, and develop-
mental neurobiology. This study also provides a milestone for
discussion about the involvement of SINEs in the generation of
new gene expression networks through shared binding sites for
particular transcription factors.
Materials and Methods
Ethics Statement
Mouse strains of B6C3F1, C57BL/6 and ICR used in this study
were purchased from Sankyo Laboratory Service Corporation
(Tokyo, Japan). This study was approved by the Ethics Committee
of Tokyo Institute of Technology.
Mouse transgenic enhancer assay and in toto X-Gal
staining
The DNA fragment of the AS021 locus was amplified by PCR
from MCH mouse genomic DNA [30] and subcloned into the
HSF51 vector containing the mouse hsp68 promoter and the
bacterial lacZ reporter gene (Figure S2; [71]). The construct was
linearized with ScaI and used for subsequent microinjection
experiments as described [72]. Transgene expression of the
AS021-HSF51 was determined in F2 embryos by X-Gal staining
as described [30]. Genotyping was performed by PCR using
genomic DNA samples extracted from yolk sacs of embryos [30].
After X-Gal staining, transgenic embryos at E11.5–15.5 were fixed
in Bouin’s solution. The fixed embryos were embedded in paraffin
for sectioning. After sectioning, tissues were counterstained with
eosin and Kernechtrot (Nuclear Fast Red) solution.
Tissue preparation, immunohistochemistry, X-Gal
staining, and in situ hybridization
Embryos were fixed by immersion in 4% paraformaldehyde
(PFA) in 0.1 M phosphate buffer (PB), pH 7.2 for 2 h at 4uC, and
postnatal animals were anesthetized and perfused with 4% PFA in
0.1 M PB for 10 min. Dissected brains were then rinsed in
phosphate-buffered saline (PBS) for 2 h, cryoprotected overnight
in 30% sucrose/0.1 M PB, and embedded in Tissue-Tek
O.C.T.
TM Compound (Sakura). Embedded tissues were sectioned
on a cryostat with a 12- to 14-mm step for embryonic stages and a
35-mm step for postnatal stages. Fluorescent immunohistochemis-
try and X-Gal staining were performed as previously described
[73]. Primary antibodies were chick anti-bgal (AbCam, 1:4000),
rabbit anti-Tbr1 (Chemicon, 1:4000), rat anti-Ctip2 (AbCam,
1:300), and mouse IgM anti-TAG1 (gift from S. Morton and T.M.
Jessell, 1:10). All fluorescent secondary antibodies were purchased
from Jackson ImmunoResearch.
For in situ hybridization at E16 or P0, NMRI wild-type mice
were retrocardially perfused using alkaline phosphate buffer (aPB;
0.1 M Na2HPO4, pH 9, Merck) containing 10% sucrose (Merck)
followed by 5% formalin (diluted from 37% formalin, Merck) in
aPB containing 25% sucrose. Mouse brains were isolated, fixed for
3–4 h in 5% formalin in aPB containing 25% sucrose, rinsed in
H2O, and embedded in Tissue-Tek O.C.T.
TM Compound
(Sakura). DIG-labeled antisense RNA probes for in situ hybridiza-
tion were synthesized by in vitro transcription. Plasmids carrying
subcloned coding regions of AS021 surrounding genes were
linearized by restriction digestion and incubated for 3 h at 37uCi n
a 20-ml reaction mixture containing 2 mg linearized template
plasmids, 2 ml1 0 6transcription buffer (Roche), 2 ml DIG-labeled
RNA mix (Roche), 0.5 ml RNase inhibitor (New England Biolabs),
2 ml T7 or Sp6 RNA polymerase (Roche), and DEPC-treated
H2O. cRNA probes were purified by lithium chloride precipitation
and monitored by gel electrophoresis.
On the first day, cross-sections (15 mm) were cut using a
cryomicrotome and collected on adhesive glass slides (Superfrost
Plus, Menzel-Glaeser, Germany). Tissue sections were immedi-
ately dried under vacuum for 30 min, fixed in 4% PFA (Merck) in
PBS pH 7.4 for 15 min, washed in PBS, and incubated with
20 mg/ml proteinase K (Merck) in 20 mM Tris, pH 7.5/1 mM
EDTA, pH 8 for 2.5 min. Proteinase K was inactivated in 0.2%
glycine (AppliChem) in PBS. Subsequently, sections were washed
in PBS, post-fixed in 4% PFA containing 0.2% glutaraldehyde
(Sigma) in PBS for 15 min, washed in PBS, and prehybridized for
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formamide (AppliChem), 56SSC, 1% blocking reagent (Roche),
5 mM EDTA, 0.1% Tween 20 (Sigma), 0.1% CHAPS (Sigma),
0.1 mg/ml heparin (Sigma), and 100 mg/ml yeast RNA (Invi-
trogen).Sections were then hybridized overnight at 68uC in the
same buffer containing denatured probes. On the second day, the
slides were washed in SSC, pH 4.5, treated with 20 mg/ml RNase
in 0.5 M NaCl/10 mM Tris for 30 min at 37uC, washed in 26
SSC, pH 4.5, washed stringently three times in 50% formamide/
26 SSC, pH 4.5 for 30 min each at 63uC, and finally washed
three times in KTBT (50 mM Tris pH 7.5, 150 mM NaCl,
10 mM KCl, 1% Triton X-100) for 10 min each. Sections were
blocked in 20% sheep serum (Sigma) in KTBT (Ab-block) for 2 h
and then incubated with anti-DIG alkaline phosphatase antibody
(Roche, 1:1000 in KTBT overnight at 4uC. On the third day,
sections were washed four times in KTBT for 30 min, washed in
NTMT (100 mM Tris, pH 9.5, 100 mM NaCl, 50 mM MgCl2,
0.1% Tween 20), and developed in NBT/BCIP (Roche) in
NTMT. The staining was monitored until signals appeared. The
stained sections were subjected to an ascending alcohol series,
cleared in 1:2 benzyl alcohol/benzyl benzoate, and finally
mounted using Eukitt (O. Kindler). Unless noted otherwise,
incubations were at room temperature and washes were done
twice for 5 min each in a slowly shaking (0.25 Hz) cuvette. All
solutions used before antibody incubation were prepared using
RNase-free (DEPC-treated) H2O.
cDNA sequences and subcloning of cRNA probe
templates
The genes surrounding AS021 in different species were
identified using the UCSC Genome Bioinformatics Site (http://
genome.ucsc.edu/) and were re-examined using the Ensembl
Genome Browser (http://www.ensembl.org/index.html). cDNA
sequences were collected from the UCSC Genome Bioinformatics
Site and re-examined using the NCBI database, and were used to
design gene-specific PCR primers (see Table S2) using Primer3
(http://frodo.wi.mit.edu/primer3/) online. Template transcripts
were amplified by PCR from an E14 or E17 cDNA pool and then
T/A subcloned into T-easy vectors (Promega) according to the
product manual. Plasmids were subjected to sequencing to verify
the existence and orientation of the appropriate inserts.
Data collection
Cells labeled by immunofluorescence were counted manually
on 12- to 14-mm sections for E11.5 to E16.5 embryonic stages and
on 35-mm sections for postnatal stages using ImageJ software.
Image acquisition
Brightfield images of brain sections were acquired using a Zeiss
Axiocam HRc camera coupled to a Zeiss Axiovert 200
microscope. Immunofluorescence images were obtained using an
inverted confocal microscope (Leica TCS SP5 AOBS tandem
resonant scanner).
Transcription factor binding sites in conserved AmnSINE1
loci
The 124 conserved AmnSINE1 sequences collected previously
[30] were surveyed for predicted transcription factor binding
sites using the UCSC Genome database. For seven transcrip-
tion factors (Oct-1, Brn-2, Cart-1, Nkx6.1, S8, SEF-1, and
CDPCR-3) found in the 39 half of the AS021 SINE locus, we
used our own Perl scripts to determine the number of AmnSINE1
loci carrying binding sites at similar locations in the AmnSINE1
consensus sequence [33]. The binding sites found were aligned
with the AmnSINE1 consensus sequence using Genetyx software
(Genetyx Corporation, Tokyo) to determine their accurate
binding sites.
Supporting Information
Figure S1 Alignment of AmnSINE1 consensus sequence
with mammalian AS021 sequences. (A) Sequence alignment
of the 39 half of the AmnSINE1 consensus sequence with eight
mammalian AS021 sequences. Colors in the AmnSINE1 consen-
sus sequence represent the 5S rRNA–derived promoter (red),
tRNA-derived region (yellow), Deu-domain (green), and 39-tail
region (blue). (B) Alignment of the AmnSINE1 consensus and
human AS021. The human AS021 locus is homologous to the 39
half (257–570 bp) of the AmnSINE1 consensus sequence but not
to the 59 half.
(TIF)
Figure S2 Schematic representation of the transgene
construct of the AS021 locus. (Top) Conservation pattern of
the 3.5-kbp region around the mouse AS021 locus. The window of
chr1:57,385,565–57,389,078 was obtained from the mm9 assem-
bly at the UCSC Genome Browser (http://genome.ucsc.edu/).
The red box indicates the location of the AS021 locus. (Bottom)
Schematic representation of the transgene construct of the AS021
locus, showing the fragment subcloned into the HSF51 vector
(gray), the mouse hsp68 promoter (dark blue), and the bacterial
lacZ reporter gene (light blue).
(TIF)
Figure S3 mRNA expression analysis of genes sur-
rounding the AS021 locus. (Top, A) Location of the AS021
locus on mouse chromosome 1. (Bottom) Genes surrounding the
AS021 locus within a 2-Mbp window. Information about
annotated genes was obtained from the UCSC Genome Browser
(http://genome.ucsc.edu/). Endogenous mRNA expression pat-
terns of the indicated genes are shown in the telencephalon at
E16.5 (Bi–Mi) and P0 (Bii–Mii).
(TIF)
Figure S4 AS021 drives lacZ expression in early-born
glutamatergic neurons. Immunostaining for Tbr1 (red) and
bgal (green) in a coronal section of an E13.5 AS021-lacZ animal.
Immunostaining of the individual proteins in the boxed regions of
(A) are shown in (B–D0). CP, cortical plate; IZ, intermediate zone;
VZ, ventricular zone. Scale bar: 200 mm.
(TIF)
Figure S5 AS021 activity decreases between P0 and P2.
(A,C) Immunostaining for bgal in coronal sections of P0 (A) and
P2 (C) AS021-lacZ animals shows a decrease in the activity of
AS021 during early postnatal stages. (B) X-Gal staining at P0
confirms the specificity of the antibody used in (A). (D) X-Gal
staining in a coronal section of a P21 AS021 cortex shows staining
similar to that observed at P2 in (C), suggesting that the decrease of
AS021 activity occurs specifically between P0 and P2. Scale bars:
100 mm.
(TIF)
Table S1 Expression of genes surrounding the AS021
locus as detected by in situ hybridization in E16 and P0
brains. P=present; N=not detected.
(TIF)
Table S2 Primers used for in situ hybridization.
(TIF)
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